+
Site Tour

PFO closure with Amplatzer™ Talisman™ PFO Occluder in patients >60 years

An analysis was performed on real-world outcomes of U.S. Medicare beneficiaries >60 years old with presumed PFO-associated stroke implanted with the Amplatzer™ PFO Occluder or the Amplatzer™ Talisman™ PFO Occluder.

Download

Related Resources

Tendyne expanded clinical study | PCR LV 2025

bRIGHT clinical data release | PCR LV 2025

Poster: Primary MR in the Very Elderly

Prognosis of TR after MitraClip for MR

TRILUMINATE Pivotal - 2-year update EuroPCR 25

bRIGHT 2-year real-world outcomes

Navitor Valve in small aortic annuli

The Amulet IDE Trial

TRENDING TOPICS

bRIGHT clinical data release | PCR LV 2025

bRIGHT procedural clipping strategy presented at PCR LV 2025 by X. Freixa

Tendyne expanded clinical study | PCR LV 2025

5-year outcomes of TMVR for severe symptomatic mitral regurgitation presented at PCR LV 2025 by A. Duncan

Navitor Active-Sealing Cuff

Navitor™ Vision* Valve: PVL sealing by unique design

CONNEXT


TV
RELATED RESOURCES

EACTS Symposium 2025

TAVI strategies for patient lifetime management

EXPAND G4 clinical data release | PCR LV 2025

TriClip Symposium | PCR LV 2025

CONNEXT


LIVE
RELATED EVENTS

TAVI webinar - key learnings in TAVI

Review the Trends | Tricuspid Focus

Debates and Controversies | Mitral Focus

Case Parade | Mitral Focus

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline